Severity Over Time of Early Forms of Spondyloarthritis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.
Eligibility criteria
Qualifiers
age >18 years;
Diagnosis of SpA confirmed by the rheumatologist with duration of symptoms <
2 years;
Signature of the written informed consent to the study
Disqualifiers
Age < 18 years;
Patients suffering from other rheumatic pathologies (even in overlap), or genetic diseases such as Marfan syndrome, Ehlers Danlos syndrome
Any medical or psychiatric condition that in the judgment of the investigator would prevent the participant from complying with the protocol or completing the study according to the protocol.
Refusal to sign the informed consent to the study.
Trial design
Treatments tested in this trial
- Diagnostic assessment
- Diagnostic assessment
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov